Dlco Or Nt-Probnp As A Screening Tool For Pah In Subjects With COPD

被引：0
|
作者：
Vanderpool, R. R. [1 ]
Risbano, M. G. [1 ]
Leo, N. [2 ]
Kessinger, C. [2 ]
Kingsley, L. [1 ]
Zhang, Y. [1 ]
Bachman, T. N. [1 ]
Simon, M. A. [1 ]
Gladwin, M. T. [3 ]
Sciurba, F. C. [2 ]
Morris, A. M. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3981
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
    Sado, Gina
    Gudmundsdottir, Katrin Kemp
    Bonander, Carl
    Ekstrom, Mattias
    Engdahl, Johan
    Svennberg, Emma
    IJC HEART & VASCULATURE, 2024, 55
  • [22] Inflammation results in increased levels of NT-proBNP and an increased NT-proBNP/BNP ratio
    Jensen, J.
    Ma, L. P.
    Fu, M.
    Hammarsten, O.
    EUROPEAN HEART JOURNAL, 2010, 31 : 281 - 281
  • [23] Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH (REPEAT-PAH)
    Durrington, C.
    Battersby, C.
    Holt, L.
    Fairman, A.
    Salisbury, T.
    Turton, H.
    Watson, L.
    Hameed, A.
    Charalampopoulos, A.
    Elliot, C.
    Rothman, A.
    Middleton, J.
    Zafar, H.
    Condliffe, R.
    Lewis, R.
    Kiely, D.
    Thompson, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [24] NT-proBNP, to be or not to be a BPD biomarker?
    Danhaive, Olivier
    Hocq, Catheline
    PEDIATRIC RESEARCH, 2024,
  • [25] ASSESSING THE REPEATABILITY OF NT-PROBNP TESTING USING LABORATORY AND POINT OF CARE TESTING IN PAH (REPEAT-PAH)
    Durrington, C.
    Battersby, C.
    Holt, L.
    Fairman, A.
    Salisbury, T.
    Turton, H.
    Watson, L.
    Harneed, A. G.
    Charalampopoulos, A.
    Elliot, C. A.
    Rothman, A. M. K.
    Middleton, J.
    Zafar, H.
    Condliffe, R.
    Lewis, R. A.
    Kiely, D. G.
    Thompson, A. A. R.
    THORAX, 2022, 77 : A101 - A101
  • [26] Utility of NT-proBNP as a screening tool for ventricular dysfunction and hypertrophy in patients with long standing Diabetes Mellitus
    Reddy, P.
    Tin, L. L.
    Loh, P. H.
    Mathur, G.
    Rigby, A. S.
    Goode, K. M.
    Clark, A. L.
    Cleland, J. G. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 13 - 13
  • [27] NT-proBNP: note ethnicity!
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (12) : 735 - 735
  • [28] NT-proBNP in Cardioembolic Stroke
    Sethi, Prahlad K.
    Rajeswari, R.
    Sethi, Nitin K.
    NEUROLOGY INDIA, 2023, 71 (04) : 866 - 867
  • [29] The biomarkers BNP and NT-proBNP
    Oremek, G. M.
    Passek, K.
    Holzgreve, F.
    von der Eltz, V.
    Droege, J.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2023, 73 (02): : 89 - 95
  • [30] Serial NT-probrain natriuretic peptide (NT-proBNP) levels in patients with pulmonary arterial hypertension (PAH)
    Mackay, L. S.
    Hughes, R.
    Peaston, R.
    MacGowan, G.
    Parry, G.
    Fisber, A. J.
    Lordan, J.
    Corris, P. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S248 - S248
12345